Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Negative regulation of ACE2 by interferons in vivo and its genetic control

View ORCID ProfileM. Azim Ansari, Emanuele Marchi, Narayan Ramamurthy, Dominik Aschenbrenner, Carl-Philipp Hackstein, STOP-HCV consortium, ISARIC-4C Investigators, Shang-Kuan Lin, Rory Bowden, Eshita Sharma, Vincent Pedergnana, Suresh Venkateswaran, Subra Kugathasan, Angela Mo, Greg Gibson, Graham Cooke, John McLauchlan, Eleanor Barnes, John Kenneth Baillie, Sarah Teichmann, Alex Mentzer, John Todd, Julian Knight, Holm Uhlig, Paul Klenerman
doi: https://doi.org/10.1101/2020.04.26.20080408
M. Azim Ansari
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Azim Ansari
  • For correspondence: ansari@well.ox.ac.uk paul.klenerman@ndm.ox.ac.uk
Emanuele Marchi
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Narayan Ramamurthy
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Aschenbrenner
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl-Philipp Hackstein
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shang-Kuan Lin
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rory Bowden
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eshita Sharma
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Pedergnana
5French National Centre for Scientific Research (CNRS), Laboratory MIVEGEC (CNRS, IRD, UM), Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suresh Venkateswaran
6Department of Pediatrics, Emory University School of Medicine and Children’s health care of Atlanta, Atlanta, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subra Kugathasan
6Department of Pediatrics, Emory University School of Medicine and Children’s health care of Atlanta, Atlanta, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Mo
7Center for Integrative Genomics, Georgia Institute of Technology, Atlanta, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Gibson
7Center for Integrative Genomics, Georgia Institute of Technology, Atlanta, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Cooke
8Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John McLauchlan
9MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, University of Glasgow, Glasgow, G61 1qh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor Barnes
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kenneth Baillie
10Edinburgh Royal Infirmary, 51 Little France crescent, Edinburgh, EH16 4SA
11Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Teichmann
12Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton Cambridge, CB10 1SA UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Mentzer
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Todd
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian Knight
4Wellcome Centre for Human Genetics, Roosevelt Dr, Headington, Oxford OX3 7BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holm Uhlig
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
13Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Klenerman
1Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
2Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK
3NIHR Biomedical Research Centre, John Radcliffe Hospital, Oxford, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ansari@well.ox.ac.uk paul.klenerman@ndm.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 pandemic has resulted in widespread morbidity and mortality globally. ACE2 is a receptor for SARS-CoV-2 and differences in expression may affect susceptibility to COVID-19. Using HCV-infected liver tissue from 195 individuals, we discovered that among genes negatively correlated with ACE2, interferon signalling pathways were highly enriched and observed down-regulation of ACE2 after interferon-alpha treatment. Negative correlation was also found in the gastrointestinal tract and in lung tissue from a murine model of SARS-CoV-1 infection suggesting conserved regulation of ACE2 across tissue and species. Performing a genome-wide eQTL analysis, we discovered that polymorphisms in the interferon lambda (IFNL) region are associated with ACE2 expression. Increased ACE2 expression in the liver was also associated with age and presence of cirrhosis. Polymorphisms in the IFNL region may impact not only antiviral responses but also ACE2 with potential consequences for clinical outcomes in distinct ethnic groups and with implications for therapeutic interventions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors would like to thank Gilead Sciences for the provision of samples and data from the BOSON clinical study for use in these analyses. The authors would also like to thank HCV Research UK (funded by the Medical Research Foundation) for their assistance in handling and coordinating the release of samples for these analyses. The authors would also like to thank ISARIC-4C investigators for their discussion and contributions to this study. This work was funded by a grant from the Medical Research Council (MR/K01532X/1-STOP-HCV Consortium). The work was supported by Core funding to the Wellcome Centre for Human Genetics provided by the Wellcome Trust (203141/Z/16/Z). This work was also supported by the Medical Research Council [grant number MC_PC_19059] and a strategic award from the Wellcome Trust (211276/Z/18/Z-WSSS). MAA is supported by a Wellcome Trust Sir Henry Dale Fellowship (220171/Z/20/Z). PK is supported as a Wellcome Trust Senior Investigator (WT 109965MA) and an NIHR Senior Investigator. PK is affiliated to the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford. EB was funded by the Medical Research Council UK, the Oxford NIHR Biomedical Research Centre and is an NIHR Senior Investigator. The work was also supported by the NIHR Biomedical Research Centre, Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The BOSON study protocol was approved by each institution review board or ethics committee before study initiation. The study was conducted in accordance with the International Conference on Harmonisation Good Clinical Practice Guidelines and the Declaration of Helsinki (clinical trial registration number: NCT01962441).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The liver gene expression read counts are submitted to Gene Expression Omnibus (GEO) under accession number GSE149601. The raw FASTQ files are currently being deposited in the European Genome-phenome Archive and the accession number will be provided when the submission is finalised. Human genotype data underlying this manuscript are deposited in the European Genome-phenome Archive under accession code EGAS00001002324. Due to patient privacy concerns the gene expression FASTQ files and the human genotype data can only be accessed by making an application to the data access committee. The Information on access to the study data is available at http://www.stop-hcv.ox.ac.uk/data-access.

http://www.stop-hcv.ox.ac.uk/data-access

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Negative regulation of ACE2 by interferons in vivo and its genetic control
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Negative regulation of ACE2 by interferons in vivo and its genetic control
M. Azim Ansari, Emanuele Marchi, Narayan Ramamurthy, Dominik Aschenbrenner, Carl-Philipp Hackstein, STOP-HCV consortium, ISARIC-4C Investigators, Shang-Kuan Lin, Rory Bowden, Eshita Sharma, Vincent Pedergnana, Suresh Venkateswaran, Subra Kugathasan, Angela Mo, Greg Gibson, Graham Cooke, John McLauchlan, Eleanor Barnes, John Kenneth Baillie, Sarah Teichmann, Alex Mentzer, John Todd, Julian Knight, Holm Uhlig, Paul Klenerman
medRxiv 2020.04.26.20080408; doi: https://doi.org/10.1101/2020.04.26.20080408
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Negative regulation of ACE2 by interferons in vivo and its genetic control
M. Azim Ansari, Emanuele Marchi, Narayan Ramamurthy, Dominik Aschenbrenner, Carl-Philipp Hackstein, STOP-HCV consortium, ISARIC-4C Investigators, Shang-Kuan Lin, Rory Bowden, Eshita Sharma, Vincent Pedergnana, Suresh Venkateswaran, Subra Kugathasan, Angela Mo, Greg Gibson, Graham Cooke, John McLauchlan, Eleanor Barnes, John Kenneth Baillie, Sarah Teichmann, Alex Mentzer, John Todd, Julian Knight, Holm Uhlig, Paul Klenerman
medRxiv 2020.04.26.20080408; doi: https://doi.org/10.1101/2020.04.26.20080408

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1095)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9766)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1557)
  • Health Policy (734)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11639)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1175)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4654)
  • Radiology and Imaging (776)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)